| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | epoxide hydrolase activity | 3.34e-07 | 11 | 115 | 4 | GO:0004301 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ether bonds | 7.17e-07 | 13 | 115 | 4 | GO:0016801 | |
| GeneOntologyMolecularFunction | ether hydrolase activity | 7.17e-07 | 13 | 115 | 4 | GO:0016803 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC16A13 SLC37A3 SLC25A14 SLC25A30 SLC46A1 SLC2A10 SLC12A3 SLC15A4 SLC7A5 SLC25A31 | 8.33e-06 | 296 | 115 | 10 | GO:0015291 |
| GeneOntologyMolecularFunction | lactose synthase activity | 9.83e-05 | 3 | 115 | 2 | GO:0004461 | |
| GeneOntologyMolecularFunction | transporter activity | SLC16A13 SLC37A3 SLC25A14 BAX BEST3 SLC25A30 SLC46A1 AQP9 MFSD14A SLC2A10 GJA4 OSBPL2 SLC12A3 SLC15A4 SLC35B4 SCN8A SLC7A5 CHRNA10 SLC25A31 | 1.37e-04 | 1289 | 115 | 19 | GO:0005215 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC16A13 SLC37A3 SLC25A14 BAX BEST3 SLC25A30 SLC46A1 AQP9 MFSD14A SLC2A10 GJA4 SLC12A3 SLC15A4 SLC35B4 SCN8A SLC7A5 CHRNA10 SLC25A31 | 1.37e-04 | 1180 | 115 | 18 | GO:0022857 |
| GeneOntologyMolecularFunction | endopeptidase activity | 1.92e-04 | 430 | 115 | 10 | GO:0004175 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | SLC16A13 SLC37A3 SLC46A1 SLC2A10 SLC15A4 SLC35B4 SLC7A5 SLC25A31 | 2.97e-04 | 293 | 115 | 8 | GO:0008514 |
| GeneOntologyMolecularFunction | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity | 3.25e-04 | 5 | 115 | 2 | GO:0003831 | |
| GeneOntologyMolecularFunction | N-acetyllactosamine synthase activity | 3.25e-04 | 5 | 115 | 2 | GO:0003945 | |
| GeneOntologyMolecularFunction | carbohydrate derivative transmembrane transporter activity | 3.72e-04 | 59 | 115 | 4 | GO:1901505 | |
| GeneOntologyMolecularFunction | solute:proton symporter activity | 3.90e-04 | 25 | 115 | 3 | GO:0015295 | |
| GeneOntologyMolecularFunction | carbohydrate binding | 4.33e-04 | 310 | 115 | 8 | GO:0030246 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC16A13 SLC37A3 SLC25A14 SLC25A30 SLC46A1 SLC2A10 SLC12A3 SLC15A4 SLC7A5 SLC25A31 | 4.38e-04 | 477 | 115 | 10 | GO:0022804 |
| GeneOntologyMolecularFunction | UDP-galactosyltransferase activity | 8.17e-04 | 32 | 115 | 3 | GO:0035250 | |
| GeneOntologyMolecularFunction | solute:inorganic anion antiporter activity | 8.17e-04 | 32 | 115 | 3 | GO:0005452 | |
| GeneOntologyMolecularFunction | galactosyltransferase activity | 1.06e-03 | 35 | 115 | 3 | GO:0008378 | |
| GeneOntologyMolecularFunction | antiporter activity | 1.22e-03 | 138 | 115 | 5 | GO:0015297 | |
| GeneOntologyMolecularFunction | peptidase activity | RELN USP9X OVCH1 ACE MMP25 TINAG PRSS47P ADAMTS18 C1S CTSB CTSW | 1.39e-03 | 654 | 115 | 11 | GO:0008233 |
| GeneOntologyMolecularFunction | cysteine-type endopeptidase activity | 1.54e-03 | 86 | 115 | 4 | GO:0004197 | |
| GeneOntologyMolecularFunction | symporter activity | 1.77e-03 | 150 | 115 | 5 | GO:0015293 | |
| GeneOntologyMolecularFunction | amide transmembrane transporter activity | 1.81e-03 | 42 | 115 | 3 | GO:0042887 | |
| GeneOntologyBiologicalProcess | multicellular organismal reproductive process | SPAG4 DRD5 SPATA31A3 INHBB USP9X SPATA31A7 BAX TRIM27 ACE SPATA31A6 SPATA31A5 CCKBR STAT5B B4GALT1 MFSD14A GMCL1 BMP4 SPATA31A1 CXCR4 CTSB SLC25A31 NPAS1 | 4.58e-07 | 1194 | 113 | 22 | GO:0048609 |
| GeneOntologyBiologicalProcess | epoxide metabolic process | 1.59e-06 | 5 | 113 | 3 | GO:0097176 | |
| GeneOntologyBiologicalProcess | developmental process involved in reproduction | SPAG4 SPATA31A3 INHBB SPATA31A7 BAX TRIM27 ACE SPATA31A6 SPATA31A5 STAT5B B4GALT1 MFSD14A GMCL1 BMP4 SPATA31A1 CXCR4 CENPI CTSB SLC25A31 | 3.96e-05 | 1235 | 113 | 19 | GO:0003006 |
| GeneOntologyBiologicalProcess | development of secondary sexual characteristics | 4.40e-05 | 13 | 113 | 3 | GO:0045136 | |
| GeneOntologyCellularComponent | external side of plasma membrane | SEMA7A ACE LEPR B4GALT1 FCGRT CXCR4 BTN1A1 SLC7A5 ASTN1 ADGRE5 LY75 CTSB | 2.93e-05 | 519 | 115 | 12 | GO:0009897 |
| GeneOntologyCellularComponent | side of membrane | SEMA7A ACE LEPR B4GALT1 MMP25 OSBPL2 FCGRT CXCR4 BTN1A1 SLC7A5 ASTN1 ADGRE5 LY75 CTSB | 3.21e-04 | 875 | 115 | 14 | GO:0098552 |
| GeneOntologyCellularComponent | cell surface | MRC1 SEMA7A RTP2 SLC46A1 ACE LEPR B4GALT1 MMP25 FCGRT CXCR4 BTN1A1 SLC7A5 ASTN1 ADGRE5 LY75 CTSB | 3.82e-04 | 1111 | 115 | 16 | GO:0009986 |
| GeneOntologyCellularComponent | mitochondrial permeability transition pore complex | 6.19e-04 | 7 | 115 | 2 | GO:0005757 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | TMEM67 GALNT1 SLC37A3 STIMATE RTP2 BAX JPH2 FAXDC2 STT3B ZDHHC12 PIGT LMF2 P4HTM SLC35B4 FADS2 ERMARD HERPUD1 | 7.01e-04 | 1293 | 115 | 17 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | TMEM67 GALNT1 SLC37A3 STIMATE RTP2 BAX JPH2 FAXDC2 STT3B ZDHHC12 PIGT LMF2 P4HTM SLC35B4 FADS2 ERMARD HERPUD1 | 7.38e-04 | 1299 | 115 | 17 | GO:0098827 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | TMEM67 GALNT1 SLC37A3 STIMATE RTP2 BAX JPH2 FAXDC2 STT3B ZDHHC12 PIGT LMF2 P4HTM SLC35B4 FADS2 ERMARD HERPUD1 | 9.34e-04 | 1327 | 115 | 17 | GO:0042175 |
| GeneOntologyCellularComponent | brush border membrane | 1.14e-03 | 83 | 115 | 4 | GO:0031526 | |
| GeneOntologyCellularComponent | secretory granule | CPPED1 SPATA31A3 SPATA31A7 OLFM4 SPATA31A6 SPATA31A5 B4GALT1 MMP25 SPATA31A1 GLB1 SLC15A4 ADGRE5 CTSB CTSW | 1.35e-03 | 1014 | 115 | 14 | GO:0030141 |
| GeneOntologyCellularComponent | brush border | 1.54e-03 | 152 | 115 | 5 | GO:0005903 | |
| GeneOntologyCellularComponent | lysosome | CPPED1 SLC37A3 OLFM4 ACE B4GALT1 TINAG GLB1 CXCR4 SLC15A4 SLC7A5 CTSB CTSW | 1.70e-03 | 811 | 115 | 12 | GO:0005764 |
| GeneOntologyCellularComponent | lytic vacuole | CPPED1 SLC37A3 OLFM4 ACE B4GALT1 TINAG GLB1 CXCR4 SLC15A4 SLC7A5 CTSB CTSW | 1.70e-03 | 811 | 115 | 12 | GO:0000323 |
| GeneOntologyCellularComponent | Golgi cisterna membrane | 1.81e-03 | 94 | 115 | 4 | GO:0032580 | |
| MousePheno | abnormal kidney calyx morphology | 1.84e-05 | 9 | 86 | 3 | MP:0004195 | |
| Domain | DUF4599 | 5.64e-07 | 12 | 111 | 4 | PF15371 | |
| Domain | DUF4599 | 5.64e-07 | 12 | 111 | 4 | IPR027970 | |
| Domain | Galactosyl_T | 7.03e-06 | 7 | 111 | 3 | IPR003859 | |
| Domain | Glyco_transf_7N | 7.03e-06 | 7 | 111 | 3 | PF13733 | |
| Domain | Glyco_transf_7C | 7.03e-06 | 7 | 111 | 3 | PF02709 | |
| Domain | Galactosyl_T_C | 7.03e-06 | 7 | 111 | 3 | IPR027791 | |
| Domain | Galactosyl_T_N | 7.03e-06 | 7 | 111 | 3 | IPR027995 | |
| Domain | Epox_hydrolase-like | 1.12e-05 | 8 | 111 | 3 | IPR000639 | |
| Domain | Pept_asp_AS | 2.38e-05 | 10 | 111 | 3 | IPR025661 | |
| Domain | Pept_C1 | 5.59e-05 | 13 | 111 | 3 | SM00645 | |
| Domain | Peptidase_C1A_C | 5.59e-05 | 13 | 111 | 3 | IPR000668 | |
| Domain | Peptidase_C1 | 5.59e-05 | 13 | 111 | 3 | PF00112 | |
| Domain | Peptidase_C1A | 5.59e-05 | 13 | 111 | 3 | IPR013128 | |
| Domain | MFS_dom | 1.49e-04 | 134 | 111 | 6 | IPR020846 | |
| Domain | MFS | 4.64e-04 | 108 | 111 | 5 | PS50850 | |
| Domain | THIOL_PROTEASE_ASN | 5.39e-04 | 27 | 111 | 3 | PS00640 | |
| Domain | Pept_cys_AS | 6.01e-04 | 28 | 111 | 3 | IPR000169 | |
| Domain | RICIN | 6.01e-04 | 28 | 111 | 3 | SM00458 | |
| Domain | RICIN_B_LECTIN | 6.01e-04 | 28 | 111 | 3 | PS50231 | |
| Domain | Ricin_B_lectin | 7.38e-04 | 30 | 111 | 3 | IPR000772 | |
| Domain | Abhydrolase_1 | 8.13e-04 | 31 | 111 | 3 | PF00561 | |
| Domain | Sugar_transporter_CS | 8.94e-04 | 32 | 111 | 3 | IPR005829 | |
| Domain | AB_hydrolase_1 | 9.79e-04 | 33 | 111 | 3 | IPR000073 | |
| Domain | MFS_1 | 1.15e-03 | 77 | 111 | 4 | PF07690 | |
| Domain | MFS | 1.15e-03 | 77 | 111 | 4 | IPR011701 | |
| Domain | - | 1.38e-03 | 81 | 111 | 4 | 3.90.550.10 | |
| Domain | Pept_his_AS | 1.86e-03 | 11 | 111 | 2 | IPR025660 | |
| Domain | Nucleotide-diphossugar_trans | 1.88e-03 | 88 | 111 | 4 | IPR029044 | |
| Domain | Mit_uncoupling | 2.22e-03 | 12 | 111 | 2 | IPR002030 | |
| Domain | OLF | 2.62e-03 | 13 | 111 | 2 | PF02191 | |
| Domain | OLF | 2.62e-03 | 13 | 111 | 2 | PS51132 | |
| Domain | CYTOCHROME_B5_2 | 2.62e-03 | 13 | 111 | 2 | PS50255 | |
| Domain | Olfac-like_dom | 2.62e-03 | 13 | 111 | 2 | IPR003112 | |
| Domain | OLF | 2.62e-03 | 13 | 111 | 2 | SM00284 | |
| Domain | CYTOCHROME_B5_1 | 2.62e-03 | 13 | 111 | 2 | PS00191 | |
| Domain | FN_type2_col-bd | 3.04e-03 | 14 | 111 | 2 | IPR000562 | |
| Domain | FN2_2 | 3.04e-03 | 14 | 111 | 2 | PS51092 | |
| Domain | Cyt-b5 | 3.04e-03 | 14 | 111 | 2 | PF00173 | |
| Domain | FN2_1 | 3.04e-03 | 14 | 111 | 2 | PS00023 | |
| Domain | - | 3.04e-03 | 14 | 111 | 2 | 3.10.120.10 | |
| Domain | fn2 | 3.04e-03 | 14 | 111 | 2 | PF00040 | |
| Domain | Cyt_B5-like_heme/steroid-bd | 3.04e-03 | 14 | 111 | 2 | IPR001199 | |
| Domain | FN2 | 3.04e-03 | 14 | 111 | 2 | SM00059 | |
| Domain | Cyt-b5 | 3.04e-03 | 14 | 111 | 2 | SM01117 | |
| Domain | - | 3.86e-03 | 53 | 111 | 3 | 1.50.40.10 | |
| Domain | Mito_carr | 3.86e-03 | 53 | 111 | 3 | PF00153 | |
| Domain | SOLCAR | 3.86e-03 | 53 | 111 | 3 | PS50920 | |
| Domain | Mitochondrial_sb/sol_carrier | 3.86e-03 | 53 | 111 | 3 | IPR018108 | |
| Domain | Mt_carrier_dom | 3.86e-03 | 53 | 111 | 3 | IPR023395 | |
| Domain | Post-SET_dom | 3.98e-03 | 16 | 111 | 2 | IPR003616 | |
| Domain | PostSET | 3.98e-03 | 16 | 111 | 2 | SM00508 | |
| Domain | POST_SET | 3.98e-03 | 16 | 111 | 2 | PS50868 | |
| Domain | - | 5.56e-03 | 119 | 111 | 4 | 3.40.50.1820 | |
| Domain | AB_hydrolase | 5.56e-03 | 119 | 111 | 4 | IPR029058 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_BENZO_A_PYRENRE_TO_CYP_MEDIATED_METABOLISM | 2.81e-05 | 11 | 80 | 3 | M47812 | |
| Pathway | REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM | 4.93e-05 | 36 | 80 | 4 | M690 | |
| Pathway | REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM | 4.93e-05 | 36 | 80 | 4 | MM14632 | |
| Pathway | REACTOME_N_GLYCAN_ANTENNAE_ELONGATION | 7.62e-05 | 15 | 80 | 3 | MM15700 | |
| Pathway | REACTOME_N_GLYCAN_ANTENNAE_ELONGATION | 7.62e-05 | 15 | 80 | 3 | M966 | |
| Pathway | WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS | 2.17e-04 | 21 | 80 | 3 | M39459 | |
| Pubmed | 2.58e-12 | 6 | 119 | 5 | 20850414 | ||
| Pubmed | Targeted disruption of the spermatid-specific gene Spata31 causes male infertility. | 2.58e-12 | 6 | 119 | 5 | 25930072 | |
| Pubmed | 1.74e-08 | 24 | 119 | 5 | 32212159 | ||
| Pubmed | 4.22e-08 | 11 | 119 | 4 | 20723587 | ||
| Pubmed | 1.56e-07 | 4 | 119 | 3 | 22798687 | ||
| Pubmed | 3.89e-07 | 5 | 119 | 3 | 23493561 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | TMEM67 SUMF2 GALNT1 PRXL2A STT3B B4GALT1 PIGT LMF2 P4HTM GLB1 CXCR4 LOXL2 FADS2 SLC7A5 ADGRE5 TMEM164 DSEL | 7.46e-07 | 1201 | 119 | 17 | 35696571 |
| Pubmed | The expanding beta 4-galactosyltransferase gene family: messages from the databanks. | 7.75e-07 | 6 | 119 | 3 | 9597550 | |
| Pubmed | SUMF2 PRXL2A STT3B MFSD14A ZDHHC12 PIGT FCGRT SLC35B4 FADS2 CTSB | 2.41e-06 | 430 | 119 | 10 | 16303743 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | SUMF2 GALNT1 USP9X PRXL2A SLC46A1 B4GALT1 SETD2 PIGT SLC15A4 SLC35B4 FADS2 CCAR2 ADGRE5 TMEM164 CTSB | 3.59e-06 | 1061 | 119 | 15 | 33845483 |
| Pubmed | 9.51e-06 | 141 | 119 | 6 | 18636124 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 15312318 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 29694640 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 15226090 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 23447104 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 17633462 | ||
| Pubmed | Genetic predisposition for development of nephropathy in type 2 diabetes mellitus. | 1.16e-05 | 2 | 119 | 2 | 23846111 | |
| Pubmed | ACE and MTHFR gene polymorphisms in unexplained recurrent pregnancy loss. | 1.16e-05 | 2 | 119 | 2 | 18588608 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 11712321 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 17275478 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 12875914 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 20518725 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 21942443 | ||
| Pubmed | Inhibition of bone morphogenic protein 4 restores endothelial function in db/db diabetic mice. | 1.16e-05 | 2 | 119 | 2 | 24202302 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 26751218 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 16906459 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 24452036 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 22554825 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 19081115 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 15893594 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 26971290 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 19039150 | ||
| Pubmed | Evaluation of the roles of common genetic mutations in leukoaraiosis. | 1.16e-05 | 2 | 119 | 2 | 11696022 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 19810824 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 19893205 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 37843720 | ||
| Pubmed | Evolutionary study of multigenic families mapping close to the human MHC class I region. | 1.16e-05 | 2 | 119 | 2 | 8114113 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 12928053 | ||
| Pubmed | MTHFR 677C>T and ACE D/I polymorphisms in migraine: a systematic review and meta-analysis. | 1.16e-05 | 2 | 119 | 2 | 19925624 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 29017962 | ||
| Pubmed | Defective glycerol metabolism in aquaporin 9 (AQP9) knockout mice. | 1.16e-05 | 2 | 119 | 2 | 17360690 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 31356773 | ||
| Pubmed | MTHFR 677C->T and ACE D/I polymorphisms and migraine attack frequency in women. | 1.16e-05 | 2 | 119 | 2 | 19673907 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 19298544 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 23458876 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 27483173 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 21769819 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 20134102 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 26416971 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 28253266 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 18337425 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 28409162 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 21338559 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 25824380 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 19857476 | ||
| Pubmed | [Polymorphisms of ACE-1 and MTHFR genes and genetic susceptibility of ischemic stroke]. | 1.16e-05 | 2 | 119 | 2 | 12194796 | |
| Pubmed | 2.12e-05 | 16 | 119 | 3 | 10580128 | ||
| Pubmed | 2.12e-05 | 16 | 119 | 3 | 38750507 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 14763962 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 34066758 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 23401650 | ||
| Pubmed | Association between genetic polymorphisms and sites of cervicocerebral artery atherosclerosis. | 3.47e-05 | 3 | 119 | 2 | 21296594 | |
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 20229631 | ||
| Pubmed | HIV-1 gp120- and gp160-induced apoptosis in cultured endothelial cells is mediated by caspases. | 3.47e-05 | 3 | 119 | 2 | 10942389 | |
| Pubmed | MTHFR and ACE gene polymorphisms and risk of vascular and degenerative dementias in the elderly. | 3.47e-05 | 3 | 119 | 2 | 19716217 | |
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 33357202 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 21567207 | ||
| Pubmed | Genetic analysis of vascular factors in Alzheimer's disease. | 3.47e-05 | 3 | 119 | 2 | 12480755 | |
| Pubmed | [Genetic determinants of hypertension in two national cohorts of Mountain Shoria]. | 3.47e-05 | 3 | 119 | 2 | 29039833 | |
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 21699409 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 17171228 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 17065682 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 16804085 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 17455988 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 39094710 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 28514598 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 26769046 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 33334892 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 17274465 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 28373165 | ||
| Pubmed | Human paraoxonase gene polymorphisms and coronary artery disease risk. | 3.47e-05 | 3 | 119 | 2 | 19280995 | |
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 32192442 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 25055800 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 23429214 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 21566062 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 24624915 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 19204075 | ||
| Pubmed | BELFAST centenarians: a case of optimised cardiovascular risk? | 3.47e-05 | 3 | 119 | 2 | 20388089 | |
| Pubmed | Expression of the chemokine receptor Cxcr4 mRNA during mouse brain development. | 3.47e-05 | 3 | 119 | 2 | 15013630 | |
| Pubmed | Endothelial nitric oxide synthase gene interactions and the risk of ischaemic stroke. | 3.47e-05 | 3 | 119 | 2 | 15595935 | |
| Pubmed | Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis. | 5.54e-05 | 118 | 119 | 5 | 19156168 | |
| Pubmed | 6.93e-05 | 4 | 119 | 2 | 35813947 | ||
| Pubmed | 6.93e-05 | 4 | 119 | 2 | 16672549 | ||
| Pubmed | 6.93e-05 | 4 | 119 | 2 | 11692002 | ||
| Pubmed | 6.93e-05 | 4 | 119 | 2 | 17024648 | ||
| Pubmed | Prevalence of thrombophilic mutations and ACE I/D polymorphism in Turkish ischemic stroke patients. | 6.93e-05 | 4 | 119 | 2 | 18387982 | |
| Pubmed | Genetic factors associated with thrombosis in pregnancy in a United States population. | 6.93e-05 | 4 | 119 | 2 | 11084577 | |
| Pubmed | 6.93e-05 | 4 | 119 | 2 | 11145975 | ||
| Pubmed | Bcl-x is not required for maintenance of follicles and corpus luteum in the postnatal mouse ovary. | 6.93e-05 | 4 | 119 | 2 | 11804960 | |
| Pubmed | Genetic polymorphisms in older subjects with vascular or Alzheimer's dementia. | 6.93e-05 | 4 | 119 | 2 | 11328206 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q12 | 1.85e-04 | 8 | 119 | 2 | chr9q12 | |
| GeneFamily | Solute carriers | SLC16A13 SLC37A3 SLC25A14 SLC25A30 SLC46A1 SLC2A10 SLC12A3 SLC15A4 SLC35B4 SLC7A5 SLC25A31 | 6.59e-07 | 395 | 75 | 11 | 752 |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 3.57e-05 | 394 | 75 | 9 | 471 | |
| GeneFamily | Beta 4-glycosyltransferases | 4.47e-05 | 17 | 75 | 3 | 425 | |
| GeneFamily | Cathepsins | 1.72e-03 | 15 | 75 | 2 | 470 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.77e-08 | 178 | 119 | 8 | 0b398656f26c4061b11ccf98908d0e2e1367585a | |
| ToppCell | myeloid-pDC|World / Lineage and Cell class | 4.59e-08 | 190 | 119 | 8 | 88c42779ce2f817d28e672d83f3f1158581edf73 | |
| ToppCell | Control-Myeloid|Control / group, cell type (main and fine annotations) | 4.78e-08 | 191 | 119 | 8 | 9c4acc5f3c2f9c0c5520863bb22f391774372347 | |
| ToppCell | medial-Hematologic-Myeloid_Dendritic_Type_1|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.06e-08 | 197 | 119 | 8 | 5bd2f32137fd849931e52093d630d2e7e27daf4f | |
| ToppCell | medial-Hematologic-Myeloid_Dendritic_Type_1-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.06e-08 | 197 | 119 | 8 | d9baa0be469fd8737a74b5078d30ce7d66759160 | |
| ToppCell | medial-2-Hematologic-Myeloid_Dendritic_Type_1|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.06e-08 | 197 | 119 | 8 | 3c1147857de6a7ab6b0cf77f5a6364d4c8669693 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.06e-08 | 197 | 119 | 8 | d669d90c3f9e98b41bcbc49dbdc5698e0b42597c | |
| ToppCell | wk_20-22-Hematologic-Myeloid-pDC|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.82e-07 | 181 | 119 | 7 | 60607c5ff6d5b1cb416adc034491dca31c41e988 | |
| ToppCell | 390C-Myeloid-Macrophage|390C / Donor, Lineage, Cell class and subclass (all cells) | 8.06e-07 | 190 | 119 | 7 | f933d971f092c4e56e9f670a9205b688c8b1ca28 | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage_3|356C / Donor, Lineage, Cell class and subclass (all cells) | 9.92e-07 | 196 | 119 | 7 | 48f7516129570981846c667a07abe5a9abe62dcd | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Dendritic_cell-DC_plasmacytoid|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.92e-07 | 196 | 119 | 7 | b10b386aacc672949560df2dbb0d4f76cf62e213 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.03e-06 | 197 | 119 | 7 | 2e3d64648a1e4f01b9256a96b94b8a640ee1824c | |
| ToppCell | Sepsis-Int-URO-Others-RBC|Int-URO / Disease, condition lineage and cell class | 1.06e-06 | 198 | 119 | 7 | 29203aaa5c1844f72289e03f585cd5e7fc498a9a | |
| ToppCell | Sepsis-Int-URO-Others|Int-URO / Disease, condition lineage and cell class | 1.06e-06 | 198 | 119 | 7 | 67f721ea8e60042317ba12efd584f56b07cfb29d | |
| ToppCell | Sepsis-Leuk-UTI-Others|Leuk-UTI / Disease, condition lineage and cell class | 1.10e-06 | 199 | 119 | 7 | e45fe91f1d1c47a305b0f39d808730723852af00 | |
| ToppCell | Sepsis-Leuk-UTI-Myeloid-pDC|Leuk-UTI / Disease, condition lineage and cell class | 1.10e-06 | 199 | 119 | 7 | 2f8d297afd26ae1e9fb66d8573274452c4133b6c | |
| ToppCell | MS-Multiple_Sclerosis-Myeloid-pDC|Multiple_Sclerosis / Disease, condition lineage and cell class | 1.10e-06 | 199 | 119 | 7 | c10c8c9322cad4996e4aa11a8680e3d781644ace | |
| ToppCell | MS-IIF-Myeloid-pDC|IIF / Disease, condition lineage and cell class | 1.10e-06 | 199 | 119 | 7 | e262ee854e64d87460bee810c14d6cbe744460e8 | |
| ToppCell | Sepsis-Leuk-UTI-Others-RBC|Leuk-UTI / Disease, condition lineage and cell class | 1.10e-06 | 199 | 119 | 7 | d9b517199a646c9461c615412ad5b58cf4bed7c8 | |
| ToppCell | normal_Lung-B_lymphocytes-GrB-secreting_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 1.10e-06 | 199 | 119 | 7 | 2f6074a2fd3323f258be03042f77929640ad0a75 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.14e-06 | 200 | 119 | 7 | 26df6ac63710655604888c3be6509b6c4befc0be | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.14e-06 | 200 | 119 | 7 | 07819a90ac347883b78d0bb3cd8c5eb0d66e1e22 | |
| ToppCell | COVID_non-vent-Lymphocytic-Dendritic-pDC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 4.59e-06 | 160 | 119 | 6 | 61f4cb4eb4313d8318aadbb99595a6cb7fd919f7 | |
| ToppCell | COVID_non-vent-Lymphocytic-Dendritic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 4.59e-06 | 160 | 119 | 6 | 34b4f710cfcb6ec370b8b074f3cbfe272f392cec | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage_4|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.75e-06 | 161 | 119 | 6 | 5cd483b73bcb3615ea56eb81c1c293e61b84b66d | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.49e-06 | 170 | 119 | 6 | 92e765ae0d3adb38d3b22fddb873fd5ccad3fd44 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.49e-06 | 170 | 119 | 6 | 9f8b215caa1afa3cd7104c06fca7cfd790640f66 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.72e-06 | 171 | 119 | 6 | 4fd2c7977c512c51507f055fc74b111c0228ed8b | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.94e-06 | 172 | 119 | 6 | f0e767a20d93e546ce278db67dbd779cc68af533 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-pDC|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.18e-06 | 173 | 119 | 6 | b571970e3ba88afc07041c5692ccfd85fc39e796 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_E|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.18e-06 | 173 | 119 | 6 | 090dc3c5bd2652a65c2490fc889da858c3af368f | |
| ToppCell | BAL-Control-Myeloid-pDC-pDC-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.42e-06 | 174 | 119 | 6 | ab654e87c7eab7f33adc61be7a86da5c4d88008d | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_E|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.42e-06 | 174 | 119 | 6 | a79ebb01a5849c314e02594a9c95009dbb03cb8c | |
| ToppCell | BAL-Control-Myeloid-pDC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.42e-06 | 174 | 119 | 6 | d9bccff5258c4277bdd1edbd87e17c327ec125e8 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-IM|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.42e-06 | 174 | 119 | 6 | f520b79d277e286c9bb5d091e6c94e7ec7e46699 | |
| ToppCell | BAL-Control-Myeloid-pDC-pDC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.42e-06 | 174 | 119 | 6 | 2453419842fd22d066631615403393bfe4449bb8 | |
| ToppCell | IIF-Myeloid-pDC|IIF / Disease, Lineage and Cell Type | 7.66e-06 | 175 | 119 | 6 | 35cfb7d0b88678ff5b83ad6e19dbc15a908a3fcc | |
| ToppCell | BAL-Control-Myeloid-pDC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.66e-06 | 175 | 119 | 6 | 6d5bdfbe53608e01c3845ecd908ca6d0fecc58f8 | |
| ToppCell | BAL-Control-Myeloid-pDC-pDC-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.66e-06 | 175 | 119 | 6 | 6839ee3bb4457d13cb08ca8eb79ae33ddd256783 | |
| ToppCell | BAL-Control-Myeloid-pDC-pDC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.66e-06 | 175 | 119 | 6 | 9d6135e183179968555670abec39dff9da2c3219 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.92e-06 | 176 | 119 | 6 | fee4e0f32aaf77294040c7af6c1f503571750d43 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-IM|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.92e-06 | 176 | 119 | 6 | adb679e69c0c17f0caee4c141bac55d03c963012 | |
| ToppCell | Control-Myeloid-pDC|Control / Disease group,lineage and cell class (2021.01.30) | 7.92e-06 | 176 | 119 | 6 | baa3563973ea1a351fe028f55828463d2a51bf1a | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.92e-06 | 176 | 119 | 6 | f25251abd4ef9fb077a978f9f9f658af58e4e0d2 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.92e-06 | 176 | 119 | 6 | b0b87eebcf5c994386b39ca607e17f10e9d9de74 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.18e-06 | 177 | 119 | 6 | ab92ffc9624850a50c88e6b8f3a517ff2251ff15 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.18e-06 | 177 | 119 | 6 | 8887ff6341eb070bdaa890cc2cd7745f0cf1b0af | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.18e-06 | 177 | 119 | 6 | 507f06d31ab773099c9431b6f433899dc97b5566 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.72e-06 | 179 | 119 | 6 | 4808469096cd6bec2bdfcf4fc55aa324757600c3 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.72e-06 | 179 | 119 | 6 | 4d55718c6afd8a038d93cc77b9b08171dab9976f | |
| ToppCell | 10x5'-Lung-Myeloid_Dendritic-migDC|Lung / Manually curated celltypes from each tissue | 9.00e-06 | 180 | 119 | 6 | e9e8992deb0beeee5548910e4616e7c990763d99 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Myeloid-pDC|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.59e-06 | 182 | 119 | 6 | 02c0824373a0ecebc922d4ca848ace9d570722c4 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.89e-06 | 183 | 119 | 6 | 103c4c4595d8daa677679fd2fa1e99cd398e56dd | |
| ToppCell | severe-Myeloid-Neutrophils_1|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 9.89e-06 | 183 | 119 | 6 | 60a6112aa4fc4f5debda4c7e81b37539ba2e4e6e | |
| ToppCell | normal_Lung-B_lymphocytes-GrB-secreting_B_cells|normal_Lung / Location, Cell class and cell subclass | 9.89e-06 | 183 | 119 | 6 | c930b957d16f9b0904b6c424acd914532e5cc137 | |
| ToppCell | cellseq-Immune-Immune_Myeloid-Myeloid_Dendritic-maDC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.89e-06 | 183 | 119 | 6 | e01dacb08a9c36cf09c0b6764ce032a7232d4cdc | |
| ToppCell | Leuk-UTI-Other-RBC|Leuk-UTI / Disease, Lineage and Cell Type | 1.05e-05 | 185 | 119 | 6 | 5b5dd856d6efc0539d92533cff134bbc3f98be45 | |
| ToppCell | Leuk-UTI-Other|Leuk-UTI / Disease, Lineage and Cell Type | 1.05e-05 | 185 | 119 | 6 | 895e8087e97ac0eab3446385e6e0dd24bea7f42c | |
| ToppCell | Multiple_Sclerosis-Myeloid-pDC|Multiple_Sclerosis / Disease, Lineage and Cell Type | 1.08e-05 | 186 | 119 | 6 | 330a4f669adea91ff9f2dff2de2210f5e3401e19 | |
| ToppCell | tumor_Lung-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 1.08e-05 | 186 | 119 | 6 | 3d7c1a281fb82db4471283f39937007d889a5f38 | |
| ToppCell | COVID-19_Severe-CD4+_CTL|COVID-19_Severe / Disease condition and Cell class | 1.08e-05 | 186 | 119 | 6 | 728d81405fdcd137097433dd676b26519185e916 | |
| ToppCell | cellseq-Immune-Immune_Myeloid-Myeloid_Dendritic-pDC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.08e-05 | 186 | 119 | 6 | d23c3318937492d7d665bec14253124c49181b5a | |
| ToppCell | myeloid-pDC|myeloid / Lineage and Cell class | 1.15e-05 | 188 | 119 | 6 | a2dc4bbeca2bdc00c51825dd65a699c54c72f241 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.15e-05 | 188 | 119 | 6 | 1f820cb19eb0e15f0eb69d07e457072bbdad8ecb | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.22e-05 | 190 | 119 | 6 | c44aae2e0d3cc84a187e12917fd8c2d7483f41d8 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.22e-05 | 190 | 119 | 6 | 705489ebbaf3d8e643498c3e507742114475fc55 | |
| ToppCell | systemic_lupus_erythematosus-managed-Myeloid-plasmacytoid_dendritic_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.26e-05 | 191 | 119 | 6 | 8c487704cbbb5eeff54e8c6fb6fffa1472b5351f | |
| ToppCell | systemic_lupus_erythematosus-managed-Myeloid-plasmacytoid_dendritic_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.26e-05 | 191 | 119 | 6 | 78d523f562d32fc408a20d99b0c61cc103241bc0 | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_immature-endo_immature_arterial2_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.26e-05 | 191 | 119 | 6 | e3fc5c92491b6e334abffbf085c00a0b5fa1aed2 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Myeloid-Macrophages|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.26e-05 | 191 | 119 | 6 | 94c7da03e5264f4d73bb507ce339a935d90279a0 | |
| ToppCell | proximal-Hematologic-Plasmacytoid_Dendritic|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.30e-05 | 192 | 119 | 6 | faead5875a54fe8f1848ae36008aae4c0f7cb1c7 | |
| ToppCell | proximal-3-Hematologic-Plasmacytoid_Dendritic|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.30e-05 | 192 | 119 | 6 | 86938c7d2bb1a7afb2b83828ca33dd137d366ec6 | |
| ToppCell | (3)_Macrophage_MARCOpos|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.30e-05 | 192 | 119 | 6 | b1e2175bd4c02106e52d8f491eea1329ac327ae9 | |
| ToppCell | proximal-Hematologic-Plasmacytoid_Dendritic-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.30e-05 | 192 | 119 | 6 | e3be395a995dc8c0ebdae754057cfa59a270cae0 | |
| ToppCell | Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.34e-05 | 193 | 119 | 6 | 8b2f89c3cf137315eed05d9edb5fc6011c5325a8 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_10|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.34e-05 | 193 | 119 | 6 | 7426a30ed01e5c8376b3e0ebe0f1057cfee88340 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC3-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.34e-05 | 193 | 119 | 6 | 30abf991ac17c18679ab7d633e7549c0ce841920 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_10|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.34e-05 | 193 | 119 | 6 | a2194012dfa0174c6160900625c44e0fd04c50e7 | |
| ToppCell | medial-Hematologic-Plasmacytoid_Dendritic|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.38e-05 | 194 | 119 | 6 | bb36274d6fe2d18c545a17d3809f331586502d01 | |
| ToppCell | 356C-Myeloid-Macrophage|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.38e-05 | 194 | 119 | 6 | 3844e6fb43ae2e0a35ea8ccc1a2e11f40b68bc67 | |
| ToppCell | Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.38e-05 | 194 | 119 | 6 | 69cf7c989ac355c459db13f9d4267b55adc3c174 | |
| ToppCell | cellseq-Immune-Immune_Myeloid-Myeloid_Dendritic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.38e-05 | 194 | 119 | 6 | 74d588de2f84a4ef112fd642f7e112a542d5ef11 | |
| ToppCell | medial-2-Hematologic-Plasmacytoid_Dendritic|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.38e-05 | 194 | 119 | 6 | d58be6454a0795d6771036a1620553a153861615 | |
| ToppCell | medial-Hematologic-Plasmacytoid_Dendritic-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.38e-05 | 194 | 119 | 6 | 0117cd68750153fd6b8978c8b4ce3589486d2b5f | |
| ToppCell | (7)_DC_2|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.42e-05 | 195 | 119 | 6 | 63abdf512368a32e586f8dc87090796f19a146c6 | |
| ToppCell | severe-B_intermediate|World / disease stage, cell group and cell class | 1.42e-05 | 195 | 119 | 6 | ce4bd004ceb05a269387adfed255d7fa393afcc6 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_monocytic-intermediate_monocyte|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.42e-05 | 195 | 119 | 6 | 403d874198a7bde626b0d0b4efad8dbb34060761 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Stem_cells|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 1.42e-05 | 195 | 119 | 6 | 2fa0216ba493d9722324c0a9a0c59c40e72b3c4e | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Stem_cells-retina_progenitors|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 1.42e-05 | 195 | 119 | 6 | 06a437459717dc3c41ec343b1ec57cf910ecbdd8 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-DC-DC3|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.42e-05 | 195 | 119 | 6 | de60fa0c69c835f0b1d6d2dba1a1acd73246b001 | |
| ToppCell | 3'_v3-Lung|World / Manually curated celltypes from each tissue | 1.46e-05 | 196 | 119 | 6 | a04f8384b734ce67ec402e64bd891a6274f04744 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_monocytic|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.46e-05 | 196 | 119 | 6 | f943519bff51c3094776fd45889dadf9062c8379 | |
| ToppCell | Biopsy_Other_PF-Immune-pDCs|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.50e-05 | 197 | 119 | 6 | 598a130eb7afb1bb95da64a964218362627feb49 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-E|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.50e-05 | 197 | 119 | 6 | 9b1c1d72c5a8c90d71ae31e4c198d2276872eaa0 | |
| ToppCell | MS-mono1|MS / Condition, Cell_class and T cell subcluster | 1.50e-05 | 197 | 119 | 6 | 32be48ee2a1397ed8f1ee8e60067dd9a96bece39 | |
| ToppCell | MS-mono1-|MS / Condition, Cell_class and T cell subcluster | 1.50e-05 | 197 | 119 | 6 | 4b038a193ecc1df65bcb608091c513ddafd6c818 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.0.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.50e-05 | 197 | 119 | 6 | bf0f64bd356584cd4f8ac68867604c2118067450 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_MHC-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.50e-05 | 197 | 119 | 6 | 0c8650bde08e1317baee4793201645d86f16e15d | |
| ToppCell | tumor_Lung-T/NK_cells-CD8+/CD4+_Mixed_Th|T/NK_cells / Location, Cell class and cell subclass | 1.50e-05 | 197 | 119 | 6 | dcce1c3dc5f3e53c368f758eb0fd5afcd86325e7 | |
| ToppCell | COVID-19_Moderate-Classical_Monocyte|COVID-19_Moderate / disease group, cell group and cell class | 1.50e-05 | 197 | 119 | 6 | 98d4107e457e7399a84439acd73bf8f59598971b | |
| Drug | nordihydroguaiaretic acid; Up 200; 1uM; PC3; HT_HG-U133A | 5.62e-06 | 197 | 111 | 8 | 1223_UP | |
| Drug | H S Q | B4GALT2 MRC1 GALNT1 B4GALT6 STT3B B4GALT1 GLB1 CXCR4 LY75 CTSB | 8.66e-06 | 351 | 111 | 10 | CID000000897 |
| Drug | Phe-arg | 1.30e-05 | 62 | 111 | 5 | CID000150903 | |
| Drug | sodium chloride | B4GALT2 MRC1 BAX ADGRL1 SI ACE B4GALT6 STT3B B4GALT1 SLC2A10 GLB1 FCGRT C1S SIGLEC1 LY75 | 2.00e-05 | 865 | 111 | 15 | CID000000206 |
| Drug | alpha-methyl-D-mannoside | 2.25e-05 | 116 | 111 | 6 | CID000002108 | |
| Drug | I 591 | 2.36e-05 | 2 | 111 | 2 | CID000006458 | |
| Drug | anisylamine | 2.40e-05 | 12 | 111 | 3 | CID000075452 | |
| Drug | 3-fluorotyrosine | 2.40e-05 | 12 | 111 | 3 | CID000092100 | |
| Drug | 2-iminothiolane | 2.40e-05 | 12 | 111 | 3 | CID000433941 | |
| Drug | raltitrexed | 2.71e-05 | 72 | 111 | 5 | CID000104758 | |
| Disease | esophagitis (is_marker_for) | 1.33e-05 | 2 | 108 | 2 | DOID:11963 (is_marker_for) | |
| Disease | mitral valve disease (is_implicated_in) | 1.33e-05 | 2 | 108 | 2 | DOID:61 (is_implicated_in) | |
| Disease | Replication Error Phenotype | 2.10e-05 | 15 | 108 | 3 | C1721098 | |
| Disease | Microsatellite Instability | 2.10e-05 | 15 | 108 | 3 | C0920269 | |
| Disease | Male sterility | 2.92e-05 | 48 | 108 | 4 | C0917731 | |
| Disease | Male infertility | 2.92e-05 | 48 | 108 | 4 | C0021364 | |
| Disease | Subfertility, Male | 2.92e-05 | 48 | 108 | 4 | C0848676 | |
| Disease | Acute Confusional Senile Dementia | 3.26e-05 | 99 | 108 | 5 | C0546126 | |
| Disease | Alzheimer's Disease, Focal Onset | 3.26e-05 | 99 | 108 | 5 | C0750900 | |
| Disease | Alzheimer Disease, Early Onset | 3.26e-05 | 99 | 108 | 5 | C0750901 | |
| Disease | Presenile dementia | 3.26e-05 | 99 | 108 | 5 | C0011265 | |
| Disease | Alzheimer Disease, Late Onset | 3.26e-05 | 99 | 108 | 5 | C0494463 | |
| Disease | Familial Alzheimer Disease (FAD) | 3.42e-05 | 100 | 108 | 5 | C0276496 | |
| Disease | coronary artery disease (is_implicated_in) | 3.42e-05 | 100 | 108 | 5 | DOID:3393 (is_implicated_in) | |
| Disease | Alzheimer's Disease | 3.58e-05 | 101 | 108 | 5 | C0002395 | |
| Disease | cholangiocarcinoma (is_implicated_in) | 6.98e-05 | 22 | 108 | 3 | DOID:4947 (is_implicated_in) | |
| Disease | collectin-12 measurement | 7.93e-05 | 4 | 108 | 2 | EFO_0020272 | |
| Disease | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | 1.14e-04 | 206 | 108 | 6 | EFO_0004612, EFO_0020947 | |
| Disease | non-arteritic anterior ischemic optic neuropathy (is_implicated_in) | 1.32e-04 | 5 | 108 | 2 | DOID:0050864 (is_implicated_in) | |
| Disease | Coronary Restenosis | 1.32e-04 | 5 | 108 | 2 | C0948480 | |
| Disease | Manic Disorder | 1.37e-04 | 71 | 108 | 4 | C0024713 | |
| Disease | free cholesterol measurement, high density lipoprotein cholesterol measurement | 1.64e-04 | 315 | 108 | 7 | EFO_0004612, EFO_0008591 | |
| Disease | proteinuria (implicated_via_orthology) | 1.80e-04 | 30 | 108 | 3 | DOID:576 (implicated_via_orthology) | |
| Disease | Manic | 1.97e-04 | 78 | 108 | 4 | C0338831 | |
| Disease | level of Phosphatidylcholine (O-18:2_18:2) in blood serum | 1.97e-04 | 6 | 108 | 2 | OBA_2045134 | |
| Disease | level of Phosphatidylcholine (O-16:0_18:2) in blood serum | 1.97e-04 | 6 | 108 | 2 | OBA_2045114 | |
| Disease | Depression, Bipolar | 2.06e-04 | 79 | 108 | 4 | C0005587 | |
| Disease | Kidney Diseases | 3.12e-04 | 88 | 108 | 4 | C0022658 | |
| Disease | clear cell renal cell carcinoma (is_implicated_in) | 3.66e-04 | 8 | 108 | 2 | DOID:4467 (is_implicated_in) | |
| Disease | 1-palmitoyl-2-linoleoyl-GPC (16:0/18:2) measurement | 3.66e-04 | 8 | 108 | 2 | EFO_0800610 | |
| Disease | 1-palmitoyl-2-stearoyl-GPC (16:0/18:0) measurement | 3.66e-04 | 8 | 108 | 2 | EFO_0800396 | |
| Disease | 1-(1-enyl-palmitoyl)-2-arachidonoyl-GPC (P-16:0/20:4) measurement | 3.66e-04 | 8 | 108 | 2 | EFO_0800423 | |
| Disease | level of Phosphatidylcholine (18:1_18:1) in blood serum | 3.66e-04 | 8 | 108 | 2 | OBA_2045099 | |
| Disease | triglyceride measurement, C-reactive protein measurement | 3.66e-04 | 38 | 108 | 3 | EFO_0004458, EFO_0004530 | |
| Disease | Melancholia | 4.59e-04 | 41 | 108 | 3 | C0025193 | |
| Disease | Nodular glomerulosclerosis | 4.59e-04 | 41 | 108 | 3 | C0017667 | |
| Disease | Depression, Neurotic | 4.59e-04 | 41 | 108 | 3 | C0282126 | |
| Disease | familial Mediterranean fever (is_implicated_in) | 4.70e-04 | 9 | 108 | 2 | DOID:2987 (is_implicated_in) | |
| Disease | pre-malignant neoplasm (implicated_via_orthology) | 4.70e-04 | 9 | 108 | 2 | DOID:0060071 (implicated_via_orthology) | |
| Disease | Depressive Syndrome | 4.93e-04 | 42 | 108 | 3 | C0086133 | |
| Disease | status epilepticus (biomarker_via_orthology) | 5.08e-04 | 100 | 108 | 4 | DOID:1824 (biomarker_via_orthology) | |
| Disease | Diabetic Nephropathy | 5.66e-04 | 44 | 108 | 3 | C0011881 | |
| Disease | level of Phosphatidylcholine (O-18:2_16:0) in blood serum | 5.86e-04 | 10 | 108 | 2 | OBA_2045132 | |
| Disease | 1-(1-enyl-palmitoyl)-2-palmitoleoyl-GPC (P-16:0/16:1) measurement | 5.86e-04 | 10 | 108 | 2 | EFO_0800464 | |
| Disease | level of phosphatidylcholine | 5.86e-04 | 10 | 108 | 2 | OBA_2040179 | |
| Disease | breast cancer (is_marker_for) | 6.07e-04 | 185 | 108 | 5 | DOID:1612 (is_marker_for) | |
| Disease | Endogenous depression | 6.46e-04 | 46 | 108 | 3 | C0011573 | |
| Disease | congestive heart failure (biomarker_via_orthology) | 6.56e-04 | 107 | 108 | 4 | DOID:6000 (biomarker_via_orthology) | |
| Disease | Mammary Carcinoma, Human | 7.08e-04 | 525 | 108 | 8 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 7.08e-04 | 525 | 108 | 8 | C1257931 | |
| Disease | Hyperhomocysteinemia | 7.14e-04 | 11 | 108 | 2 | C0598608 | |
| Disease | obstructive sleep apnea (is_implicated_in) | 7.14e-04 | 11 | 108 | 2 | DOID:0050848 (is_implicated_in) | |
| Disease | Mammary Neoplasms | 7.26e-04 | 527 | 108 | 8 | C1458155 | |
| Disease | Breast Carcinoma | 8.29e-04 | 538 | 108 | 8 | C0678222 | |
| Disease | 1-(1-enyl-palmitoyl)-2-palmitoyl-GPC (P-16:0/16:0) measurement | 8.55e-04 | 12 | 108 | 2 | EFO_0800466 | |
| Disease | nervous system disorder | 9.78e-04 | 53 | 108 | 3 | C0027765 | |
| Disease | level of Phosphatidylcholine (16:0_18:3) in blood serum | 1.01e-03 | 13 | 108 | 2 | OBA_2045072 | |
| Disease | level of Phosphatidylcholine (18:1_18:2) in blood serum | 1.17e-03 | 14 | 108 | 2 | OBA_2045100 | |
| Disease | malignant pleural mesothelioma (is_marker_for) | 1.17e-03 | 14 | 108 | 2 | DOID:7474 (is_marker_for) | |
| Disease | anemia (is_implicated_in) | 1.17e-03 | 14 | 108 | 2 | DOID:2355 (is_implicated_in) | |
| Disease | phospholipid measurement, high density lipoprotein cholesterol measurement | 1.20e-03 | 321 | 108 | 6 | EFO_0004612, EFO_0004639 | |
| Disease | cleft lip (is_implicated_in) | 1.35e-03 | 15 | 108 | 2 | DOID:9296 (is_implicated_in) | |
| Disease | level of Phosphatidylcholine (O-18:1_20:4) in blood serum | 1.35e-03 | 15 | 108 | 2 | OBA_2045131 | |
| Disease | level of Phosphatidylcholine (16:0_16:0) in blood serum | 1.35e-03 | 15 | 108 | 2 | OBA_2045067 | |
| Disease | high density lipoprotein cholesterol measurement, metabolic syndrome | 1.35e-03 | 15 | 108 | 2 | EFO_0000195, EFO_0004612 | |
| Disease | lipid metabolism disorder (implicated_via_orthology) | 1.35e-03 | 15 | 108 | 2 | DOID:3146 (implicated_via_orthology) | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Positive | 1.39e-03 | 131 | 108 | 4 | C4704862 | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Negative | 1.39e-03 | 131 | 108 | 4 | C4552091 | |
| Disease | Juvenile arthritis | 1.39e-03 | 131 | 108 | 4 | C3495559 | |
| Disease | Juvenile psoriatic arthritis | 1.39e-03 | 131 | 108 | 4 | C3714758 | |
| Disease | osteosarcoma (is_implicated_in) | 1.54e-03 | 16 | 108 | 2 | DOID:3347 (is_implicated_in) | |
| Disease | level of Sterol ester (27:1/18:0) in blood serum | 1.54e-03 | 16 | 108 | 2 | OBA_2045196 | |
| Disease | autosomal recessive polycystic kidney disease (implicated_via_orthology) | 1.54e-03 | 16 | 108 | 2 | DOID:0110861 (implicated_via_orthology) | |
| Disease | level of Phosphatidylcholine (18:0_18:2) in blood serum | 1.54e-03 | 16 | 108 | 2 | OBA_2045090 | |
| Disease | Juvenile-Onset Still Disease | 1.55e-03 | 135 | 108 | 4 | C0087031 | |
| Disease | Renal Insufficiency | 1.74e-03 | 17 | 108 | 2 | C1565489 | |
| Disease | renal fibrosis (implicated_via_orthology) | 1.74e-03 | 17 | 108 | 2 | DOID:0050855 (implicated_via_orthology) | |
| Disease | Huntington Disease | 1.74e-03 | 17 | 108 | 2 | C0020179 | |
| Disease | Vascular Diseases | 1.74e-03 | 17 | 108 | 2 | C0042373 | |
| Disease | phospholipid measurement | 1.78e-03 | 140 | 108 | 4 | EFO_0004639 | |
| Disease | total lipids in very large HDL measurement | 1.85e-03 | 66 | 108 | 3 | EFO_0022312 | |
| Disease | phospholipids in very large HDL measurement | 1.85e-03 | 66 | 108 | 3 | EFO_0022298 | |
| Disease | stomach cancer (is_marker_for) | 1.87e-03 | 142 | 108 | 4 | DOID:10534 (is_marker_for) | |
| Disease | Bipolar Disorder | 1.89e-03 | 477 | 108 | 7 | C0005586 | |
| Disease | non-alcoholic fatty liver disease (is_implicated_in) | 1.95e-03 | 18 | 108 | 2 | DOID:0080208 (is_implicated_in) | |
| Disease | level of Phosphatidylcholine (15:0_18:2) in blood serum | 1.95e-03 | 18 | 108 | 2 | OBA_2045065 | |
| Disease | cholesterol in very large HDL measurement | 2.10e-03 | 69 | 108 | 3 | EFO_0022229 | |
| Disease | ankylosing spondylitis (is_implicated_in) | 2.18e-03 | 19 | 108 | 2 | DOID:7147 (is_implicated_in) | |
| Disease | sodium-coupled monocarboxylate transporter 1 measurement | 2.18e-03 | 19 | 108 | 2 | EFO_0802076 | |
| Disease | citrulline measurement | 2.42e-03 | 20 | 108 | 2 | EFO_0009777 | |
| Disease | level of Phosphatidylcholine (16:0_18:2) in blood serum | 2.42e-03 | 20 | 108 | 2 | OBA_2045071 | |
| Disease | attention deficit hyperactivity disorder (is_implicated_in) | 2.42e-03 | 20 | 108 | 2 | DOID:1094 (is_implicated_in) | |
| Disease | platelet crit | 2.61e-03 | 952 | 108 | 10 | EFO_0007985 | |
| Disease | Dermatologic disorders | 2.66e-03 | 75 | 108 | 3 | C0037274 | |
| Disease | level of Phosphatidylcholine (16:1_18:2) in blood serum | 2.66e-03 | 21 | 108 | 2 | OBA_2045083 | |
| Disease | phosphatidylcholine 34:3 measurement | 2.92e-03 | 22 | 108 | 2 | EFO_0010377 | |
| Disease | transitional cell carcinoma (is_implicated_in) | 2.92e-03 | 22 | 108 | 2 | DOID:2671 (is_implicated_in) | |
| Disease | Granulomatous Slack Skin | 2.92e-03 | 22 | 108 | 2 | C0376407 | |
| Disease | Kidney Failure | 2.92e-03 | 22 | 108 | 2 | C0035078 | |
| Disease | Lung Neoplasms | 2.96e-03 | 265 | 108 | 5 | C0024121 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YWVPFIWFGNLATKA | 181 | Q8N1M1 | |
| WTDAYLRWDPNAYGG | 86 | Q9GZZ6 | |
| KWWRFAEFQYLQPGP | 401 | Q8N163 | |
| VFRAGNNFWWIPVVG | 236 | O43315 | |
| WWTTGKYGIFQYDGP | 426 | Q9H993 | |
| QFLTINGFPNNYWGW | 296 | P15291 | |
| LRINGFPNEYWGWGG | 266 | O60909 | |
| VGIGAWNYPFQIASW | 151 | P49189 | |
| NGGYPAEAWNFWTRK | 151 | P07858 | |
| LPFWAVDAVANWYFG | 91 | P61073 | |
| PFGYLVDQWRWGVFS | 466 | P12821 | |
| NGFWAVELYGNGYWA | 391 | Q13410 | |
| WLRVDNYFIWSFIGP | 996 | O94910 | |
| PRYCWLDFEQGFLWS | 681 | P48960 | |
| NWQRFGLWNFPFGTI | 421 | Q86UB2 | |
| GAFNPQWVSVTYGIW | 26 | Q8N6T3 | |
| SQEDQWYLGYPGDQW | 31 | Q8IYA2 | |
| WYLDYPGDQWSLGFS | 36 | Q6NUI1 | |
| RGPGFWDAFASRWQQ | 106 | A0A0U1RR37 | |
| SQWPFRQGYGGLDWA | 1106 | Q5TGY3 | |
| WLPVYSANTWRAFDG | 346 | P32239 | |
| GWNDWIVAPPGYQAF | 321 | P12644 | |
| FGKPWWQGSYYEVGR | 116 | Q6P9G0 | |
| WGTNQGPWPYTIFQR | 511 | O14525 | |
| AEYNSKPFRGWFYQW | 656 | Q8TE60 | |
| EYCWRWTGFNFGFDL | 406 | Q96IK5 | |
| WYNYLPDGQGWVGDV | 421 | Q9NXG6 | |
| WFGWANSSLNPVIYA | 346 | P21918 | |
| GYTPYGWLQLSWFQQ | 161 | Q15011 | |
| GYYRWLQRAGGFVWL | 366 | Q99742 | |
| GFSVGDFWIRWYQQK | 46 | A0A0A0MRZ9 | |
| ENERASGYFTRPWQW | 106 | O75884 | |
| IAWFTVFYFGNGWIP | 146 | O95864 | |
| WLAVYFFTSGNEGNW | 301 | P32926 | |
| NIRGETFFFKGPWFW | 326 | Q9NPA2 | |
| YRTQEWDEFPNGRWG | 376 | P42898 | |
| QYWPDQGCWTYGNIR | 246 | P23469 | |
| HWLRAQGYANPFWLA | 201 | Q96NT5 | |
| SWNFGFEVAGVYTWP | 41 | Q9BR39 | |
| WRGWGAREFDIFYQS | 1986 | Q38SD2 | |
| GFPEFWYSWRYQLRE | 101 | Q8IUS5 | |
| YALNYALAGTPWGWR | 151 | O95528 | |
| GWNDWIIAPTGYYGN | 316 | P09529 | |
| GLGFASNAFQETWYW | 481 | Q9Y4K0 | |
| VWINGFNLGRYWPAR | 581 | P16278 | |
| AFWVSGWLGPQQYLS | 46 | P55899 | |
| PAFLTQGWGSTYQAW | 481 | Q96I24 | |
| LSGLPVYFFGVWWKN | 466 | Q01650 | |
| FWIGLNQLYSARGWE | 276 | O60449 | |
| LDGLGYWSNWSNPAY | 616 | P48357 | |
| WWKGDYGTRIQQYFP | 806 | P16885 | |
| GAWLFSGSYNRVQLW | 11 | P18054 | |
| NFFRSLWGPYAGWAQ | 301 | O15527 | |
| LWGPYAGWAQAVLFS | 306 | O15527 | |
| QILQLAWYGFGSEPW | 321 | Q96MC6 | |
| DAKQFGIQFRWWQPY | 831 | P78509 | |
| WNQLQAFWGTGKGYF | 141 | Q7Z3B4 | |
| YGGFNWKLNFRWYPV | 256 | Q10472 | |
| RFWGASGYFWQAQWE | 51 | Q96IV6 | |
| FWRWFLANLASGGAA | 121 | Q9H0C2 | |
| WYSWRYQIPALAQAG | 271 | P34913 | |
| EGFFALYKGFWPNWL | 256 | Q5SVS4 | |
| QFRKINGFPNAFWGW | 276 | Q9UBX8 | |
| DQFWSYWNRFGPGLV | 231 | Q9Y2V0 | |
| WIQDQGGWDGLLSYF | 151 | Q07812 | |
| PFWKRYLDGWNAIFS | 266 | Q02318 | |
| NSWGAQWGEKGYFRL | 331 | P56202 | |
| WQVFFDNPWAGGALI | 451 | P09871 | |
| SQEDQWYLGYPGDQW | 31 | Q3MJ40 | |
| WGDDYFSFWVGGVLF | 146 | Q9BRF8 | |
| FPENWFSWRYQLREF | 106 | Q9H6B9 | |
| TKGQFEIRYAPWFQW | 86 | Q5T6L9 | |
| EAGFLYGQWRLYGWT | 166 | P35212 | |
| SQGDQWYLGYPGDQW | 31 | A2RUR9 | |
| WSWYLDYLFSQGLQG | 716 | Q92674 | |
| RGPEATRRFFNWFYW | 186 | Q8N697 | |
| FQPYSWIDGWRSFNP | 451 | Q8IZU8 | |
| SISFWRQNLPWLFYG | 286 | Q5HYA8 | |
| FNSGWQWSDRSPFRY | 286 | P22897 | |
| AIWPFRFGYDNEGWS | 431 | Q9H720 | |
| GSGYNFLSLRWCLFW | 191 | Q5QGT7 | |
| WWVREGFFKPEYQAR | 116 | Q5ST30 | |
| YYVPRGFWKQFRLWG | 1661 | Q93008 | |
| VYPWGNWFQPNRTNL | 181 | Q8NBJ7 | |
| APQNGFWAVSLWYGK | 401 | P14373 | |
| NDGFQAFVWWLLGIG | 151 | Q969S0 | |
| RYKYWFSQPGEQGQW | 561 | Q9BU23 | |
| ESFWKNYSQLFWGLP | 406 | Q5VVP1 | |
| WPWQVGLRFLGDYQC | 586 | Q7RTY7 | |
| ESFWKNYSQLFWGLP | 406 | Q8IWB4 | |
| IYGGRDAAAGQWPWQ | 81 | A8MTI9 | |
| WAYGNDLDARPWDFQ | 751 | Q5VSL9 | |
| AKWYQRGYCWEGPNF | 31 | A0A1B0GVV1 | |
| FGPGTANERTVQWWF | 376 | Q53H47 | |
| ENLPGRNYTFWQWFD | 561 | P51692 | |
| WDSWLPGFAFNDQFI | 1086 | P14410 | |
| QLNWRGFSYLYGAWG | 261 | Q6UX06 | |
| WNRFSFWNYARPPTV | 286 | Q9NPE6 | |
| EAEWQTRWFYPGNNP | 441 | Q9H1P3 | |
| LGVWYNFFRAWNGGF | 156 | Q9BRX8 | |
| ESFWKNYSQLFWGLP | 406 | Q5VYP0 | |
| GFFALYKGFWPNWLR | 291 | O95258 | |
| WGWEAGFDPQIGVYY | 61 | Q6AWC2 | |
| APFFQWLLSHYAWRG | 156 | Q7RTY0 | |
| QGFWRTRYWGPPFLQ | 91 | Q969N2 | |
| ESFWKNYSQLFWGLP | 406 | Q5TZJ5 | |
| FWLPFYLSNNFGWKE | 311 | Q8NCC5 | |
| ESFWKNYSQLFWGLP | 406 | Q5VU36 | |
| PFYGPWYRIWASGHQ | 246 | Q5U3C3 | |
| EFLNWFDERAWYPLG | 121 | Q8TCJ2 | |
| SWFGDTRYAWKNGNL | 706 | Q9UKY1 | |
| PGWRPSFQYYNKWAA | 556 | P55017 | |
| GFTFLRDPWNWLDFS | 186 | Q9UQD0 | |
| WRDTRVYGVFSNPWN | 316 | O75326 | |
| NFSWFRNGVLWAQGP | 741 | Q9BZZ2 | |
| WQQWESLRFGEYGDP | 131 | Q86TL2 | |
| TRDYWQGNGYWDPRS | 1296 | Q9BYW2 | |
| YLTGWQPRWFVLDNG | 11 | Q9HB20 | |
| GLYLAWSGLRFFQPW | 156 | Q96GR4 | |
| NSWGKSWGENGYFRI | 436 | Q9UJW2 | |
| FSSAWNYFAGWRNPQ | 341 | Q9C037 |